Pro Medicus, Vitestro and Radiobotics: Imaging AI Shifts to Operating Proof – August 21, 2026
Pro Medicus, Vitestro and Radiobotics show why imaging AI value now depends on activation, lifecycle evidence and renewal economics for providers and investors. The strategic question in medical imaging and AI-enabled MedTech is changing. Regulatory authorization remains necessary, but it no longer provides enough evidence of commercial strength. The more important test is what happens […]
Teledyne, RadNet, Heartflow and Aidoc Shift Medical Imaging Value Toward Monetization Control – August 14, 2026
Teledyne, RadNet, Heartflow and Aidoc show how imaging value is shifting toward component control, workflow, payment and repeat paid use. 🎧 Listen to this week’s Marketstrat Pulse Insight: Medical imaging companies have historically been judged by the assets they sell, the technologies they clear and the number of sites they reach. The stronger signals from […]
GE HealthCare, MARS Bioimaging, QT Imaging and Hyperfine Show Why Imaging Capacity Is Moving from Rooms to Networks – August 7, 2026
Medical imaging capacity is entering a new phase. Scanner count still matters, but it no longer provides a sufficient view of how much clinical work an imaging organization can complete. The more useful measure is productive capacity: the number of studies that move from referral and authorization through acquisition, interpretation, reporting and payment. This week’s […]
Caristo, DeepHealth, ThinkSono and 4DMedical Shift Imaging AI Toward Service-Line Economics – July 31, 2026
Medical imaging AI is entering a more demanding commercialization phase. Regulatory authorization, technical performance and access to a large study pool remain important. They do not establish market adoption on their own. The decisive question is conversion: how many eligible studies move through an activated workflow, produce a usable result, receive appropriate human review, meet […]
Johnson & Johnson, GE HealthCare, DeepHealth and CARPL.ai Shift Imaging AI Toward Decision Infrastructure – July 24, 2026
Johnson & Johnson, GE HealthCare, DeepHealth and CARPL.ai show imaging AI moving from model access to governed clinical action. Medical imaging AI is entering a more demanding phase of commercialization. Model availability continues to expand, but the strategic contest is moving to the infrastructure that converts technical output into a standardized, governed and completed clinical […]
CMS, GE HealthCare, Sectra and Provect AI Reshape Imaging Capacity – July 17, 2026
Marketstrat analyzes how CMS, GE HealthCare, Sectra and Provect AI are shifting imaging value toward capacity, workflow control and governance. 🎧 Listen to this week’s Marketstrat Pulse Insight: CMS, GE HealthCare, Sectra and Provect AI Signal a New Imaging Capacity-Control Market Medical imaging has traditionally evaluated value at the level of the asset or algorithm. […]
CMS, Heartflow, Cleerly, Viz.ai and Philips Reframe Imaging AI Economics – July 10, 2026
Marketstrat analyzes how CMS, Heartflow, Cleerly, Viz.ai and Philips are shifting imaging AI toward payment, workflow control and capacity. 🎧 Listen to this week’s Marketstrat Pulse Insight: Medical imaging AI is entering a more demanding stage of commercialization. Regulatory clearance still matters, but the week ending July 10, 2026 showed that payment architecture, workflow control […]
Aidoc, DeepHealth/RadNet, GuideAI and HOPPR Move Imaging AI Beyond Clearance – June 26, 2026
The week ending June 26 showed that imaging AI adoption now depends on workflow governance, platform layering, reimbursement, enterprise distribution and supply resilience. Imaging AI activity resumed across CT, MRI and mammography, but the week’s bigger signal was not clearance volume. Aidoc and HOPPR moved report drafting toward the next workflow frontier. DeepHealth/RadNet expanded mammography […]
Midjourney Medical, Butterfly Network and AIRS Medical Shift Imaging AI Toward Distribution, Capacity and Regulated Updates – June 19, 2026
Consumer-led imaging, embedded ultrasound components, MRI capacity software and FDA’s controlled-update framework are expanding the definition of an imaging AI platform. Estimated read time: 6 minutes The most consequential imaging AI signals this week were not additional point algorithms. Midjourney Medical tested a consumer-led distribution model, Butterfly Network expanded ultrasound into embedded component licensing, AIRS […]
RadNet/DeepHealth, GE HealthCare and Rad AI Turn Reporting AI Into Imaging’s Control Layer – June 12, 2026
The week ending June 12 showed imaging AI moving beyond point algorithms and into reporting workflow, enterprise imaging workspaces, validation infrastructure, and operational capacity. This week’s Marketstrat Pulse points to a structural shift in imaging AI. The highest-signal activity was not another standalone detection model. It was the concentration of reporting-native AI, cloud enterprise imaging, […]
